Carteolol drug interactions: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi- (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
Ocupress should be used with caution in patients who are receiving a beta-adrenergic blocking agent orally, because of the potential for additive effects on systemic [[beta-blockade]]. | Ocupress should be used with caution in patients who are receiving a beta-adrenergic blocking agent orally, because of the potential for additive effects on systemic [[beta-blockade]]. | ||
Close observation of the patient is recommended when a [[beta-blocker]] is administered to patients receiving [[catecholamine]]-depleting drugs such as [[reserpine]], because of possible additive effects and the production of [[hypotension]] and/or marked [[bradycardia]], which may produce [[vertigo]], [[syncope]], or [[postural hypotension]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a11548a0-9c0f-4729-907c-75d8f99a6c85 | publisher = | date = | accessdate = 4 February 2014 }}</ref> | Close observation of the patient is recommended when a [[beta-blocker]] is administered to patients receiving [[catecholamine]]-depleting drugs such as [[reserpine]], because of possible additive effects and the production of [[hypotension]] and/or marked [[bradycardia]], which may produce [[vertigo]], [[syncope]], or [[postural hypotension]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a11548a0-9c0f-4729-907c-75d8f99a6c85 | publisher = | date = | accessdate = 4 February 2014 }}</ref> | ||
==References== | ==References== | ||
Revision as of 15:27, 13 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Drug Interactions
Ocupress should be used with caution in patients who are receiving a beta-adrenergic blocking agent orally, because of the potential for additive effects on systemic beta-blockade. Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may produce vertigo, syncope, or postural hypotension.[1]
References
- ↑ "ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.]". Retrieved 4 February 2014.